æ–°åž‹å† çŠ¶ç—…æ¯’(2019-nCoV)疫情æ£åœ¨è¿…速å‘å…¨çƒè”“延。截æ¢2020å¹´3月6日,全çƒç´¯è®¡98373人, 累计æ»äº¡3388人。由于目å‰æ²¡æœ‰ç‰¹æ•ˆè¯å¯ä»¥æ²»ç–—æ–°å† è‚ºç‚Žï¼Œæ²»ç–—æ–°å† è‚ºç‚Žçš„è¯ç‰©ç ”å‘迫在眉ç«ã€‚通过以AI为架构的è¯ç‰©ç›é€‰æ‰‹æ®µï¼Œå¯ä»¥å‘现多ç§å¯èƒ½å¯¹2019-nCoV有治疗作用的è¯ç‰©åŠåŒ–åˆç‰©ã€‚阿拉ä¸æä¾›ä»¥ä¸‹å‡ å款试剂作为æ¤è¯ç‰©ç ”å‘çš„ç ”å‘用æ料。
韩国Deargenå…¬å¸ã€ç¾Žå›½ä½æ²»äºšå·žäºšç‰¹å…°å¤§å¸‚埃默里大å¦ã€éŸ©å›½å¤©å®‰å¸‚担国大å¦è‡ªç„¶ç§‘å¦å¦é™¢è”,利用è¯ç‰©-é¶ç‚¹ç›¸äº’作用模型(MT-DTIï¼‰ï¼Œé¢„æµ‹äº†ä¸Žæ–°åž‹å† çŠ¶ç—…æ¯’(2019-nCoV) 3Cæ ·è›‹ç™½é…¶ã€RNAä¾èµ–RNAèšåˆé…¶ã€è§£æ—‹é…¶ã€3 '- 5 'æ ¸é…¸å¤–åˆ‡é…¶ã€å†…切RNAé…¶ã€å†…切RNA酶的è¯ç‰©åŠåŒ–åˆç‰©ã€‚
æŠ‘åˆ¶æ–°åž‹å† çŠ¶ç—…æ¯’(2019-nCoV) 3Cæ ·è›‹ç™½é…¶çš„DTI预测结果
é¡¹ç›®å· |
产å“å称 |
纯度 |
CAS |
è§„æ ¼ |
A125825 |
Atazanavir
阿扎那韦 |
- |
198904-31-3 |
10mg,50mg,250mg,5g |
E135556 |
Efavirenz
ä¾æ³•éŸ¦ä»‘ |
≥98%(HPLC) |
154598-52-4 |
10mg,50mg,250mg,1g,5g |
R126586 |
利托那韦
Ritonavir |
≥98% |
155213-67-5 |
10mg,50mg,250mg,500mg |
D127636 |
多替拉韦
Dolutegravir |
≥99% |
1051375-16-6 |
5mg,10mg,50mg |
A126103 |
Asunaprevir
阿那匹韦 |
≥98% |
630420-16-5 |
5mg,10mg,50mg,250mg |
S127117 |
Simeprevir
西咪匹韦 |
≥99% |
923604-59-5 |
5mg,10mg,50mg,100mg |
æŠ‘åˆ¶æ–°åž‹å† çŠ¶ç—…æ¯’(2019-nCoV)çš„RNAä¾èµ–RNAèšåˆé…¶çš„DTI预测结果
é¡¹ç›®å· |
产å“å称 |
纯度 |
CAS |
è§„æ ¼ |
M124903 |
MK-5172 |
98% |
1350514-68-9 |
5mg,10mg |
G129109 |
Ganciclovir
更昔洛韦 |
≥98.0% |
82410-32-0 |
1g,5g,25g,100g |
A125825 |
Atazanavir
阿扎那韦 |
- |
198904-31-3 |
10mg,50mg,250mg,5g |
D127186 |
Daclatasvir(BMS-790052) |
≥98% |
1009119-64-5 |
10mg,50mg,250mg |
E126710 |
Etravirine (TMC125) |
≥95% |
269055-15-4 |
5mg,25mg,100mg,1g |
E181466 |
Entecavir
æ©æ›¿å¡éŸ¦ |
98% |
142217-69-4 |
250mg,1g |
E135556 |
Efavirenz
ä¾æ³•éŸ¦ä»‘ |
≥98%(HPLC) |
154598-52-4 |
10mg,50mg,250mg,1g,5g |
A126103 |
Asunaprevir
阿那匹韦 |
≥98% |
630420-16-5 |
5mg,10mg,50mg,250mg |
A126552 |
Abacavir
阿巴å¡éŸ¦ |
≥98.0% |
136470-78-5 |
1g,5g |
D127636 |
多替拉韦
Dolutegravir |
≥99% |
1051375-16-6 |
5mg,10mg,50mg |
V127611 |
VX-222 (VCH-222, Lomibuvir) |
≥99% |
1026785-59-0 |
5mg,10mg,50mg |
P125160 |
Penciclovir
喷昔洛韦 |
≥99% |
39809-25-1 |
50mg,250mg,1g |
D127014 |
Danoprevir (ITMN-191) |
≥95% |
850876-88-9 |
2mg,5mg,25mg |
R126586 |
利托那韦
Ritonavir |
≥98% |
155213-67-5 |
10mg,50mg,250mg,500mg |
S126514 |
沙奎那韦
Saquinavir |
≥98% |
127779-20-8 |
25mg,100mg |
R129802 |
Raltegravir(MK-0518) |
≥97% |
518048-05-0 |
5mg,10mg,50mg,1g |
æŠ‘åˆ¶æ–°åž‹å† çŠ¶ç—…æ¯’(2019-nCoV)的解旋酶的DTI预测结果
é¡¹ç›®å· |
ä¸æ–‡å称 |
è§„æ ¼ |
CAS |
包装 |
S127117 |
Simeprevir
西咪匹韦 |
≥99% |
923604-59-5 |
5mg,10mg,50mg,100mg |
A125825 |
Atazanavir
阿扎那韦 |
- |
198904-31-3 |
10mg,50mg,250mg,5g |
M124903 |
MK-5172 |
98% |
1350514-68-9 |
5mg,10mg |
A126103 |
Asunaprevir
阿那匹韦 |
≥98% |
630420-16-5 |
5mg,10mg,50mg,250mg |
T126775 |
Telaprevir
特拉匹韦 |
≥98% |
402957-28-2 |
5mg,10mg,50mg |
R126586 |
利托那韦
Ritonavir |
≥98% |
155213-67-5 |
10mg,50mg,250mg,500mg |
L299096 |
洛比那韦
Lopinavir |
95% |
192725-17-0 |
10mg,50mg,250mg,1g |
L129320 |
洛比那韦
Lopinavir |
≥99% |
192725-17-0 |
10mg,50mg,100mg,250mg,1g |
D125841 |
达芦那韦
Darunavir |
98% |
206361-99-1 |
5mg,10mg,50mg,250mg,1g |
G129109 |
Ganciclovir
更昔洛韦 |
≥98.0% |
82410-32-0 |
1g,5g,25g,100g |
P125160 |
Penciclovir
喷昔洛韦 |
≥99% |
39809-25-1 |
50mg,250mg,1g |
E126710 |
Etravirine (TMC125) |
≥95% |
269055-15-4 |
5mg,25mg,100mg,1g |
R129802 |
Raltegravir(MK-0518) |
≥97% |
518048-05-0 |
5mg,10mg,50mg,1g |
D127636 |
多替拉韦
Dolutegravir |
≥99% |
1051375-16-6 |
5mg,10mg,50mg |
N137745 |
奈éžé‚£éŸ¦
Nelfinavir Mesylate |
98% |
159989-65-8 |
10mg,50mg,250mg |
E135556 |
Efavirenz
ä¾æ³•éŸ¦ä»‘ |
≥98%(HPLC) |
154598-52-4 |
10mg,50mg,250mg,1g,5g |
E181466 |
Entecavir
æ©æ›¿å¡éŸ¦ |
98% |
142217-69-4 |
250mg,1g |
R126586 |
利托那韦
Ritonavir |
≥98% |
155213-67-5 |
10mg,50mg,250mg,500mg |
V127611 |
VX-222 (VCH-222, Lomibuvir) |
≥99% |
1026785-59-0 |
5mg,10mg,50mg |
æŠ‘åˆ¶æ–°åž‹å† çŠ¶ç—…æ¯’(2019-nCoV)çš„3 '- 5 'æ ¸é…¸å¤–åˆ‡é…¶çš„DTI预测结果
é¡¹ç›®å· |
ä¸æ–‡å称 |
è§„æ ¼ |
CAS |
包装 |
S127117 |
Simeprevir
西咪匹韦 |
≥99% |
923604-59-5 |
5mg,10mg,50mg,100mg |
E135556 |
Efavirenz
ä¾æ³•éŸ¦ä»‘ |
≥98%(HPLC) |
154598-52-4 |
10mg,50mg,250mg,1g,5g |
D127014 |
Danoprevir (ITMN-191) |
≥95% |
850876-88-9 |
2mg,5mg,25mg |
G129109 |
Ganciclovir
更昔洛韦 |
≥98.0% |
82410-32-0 |
1g,5g,25g,100g |
P125160 |
Penciclovir
喷昔洛韦 |
≥99% |
39809-25-1 |
50mg,250mg,1g |
A125825 |
Atazanavir
阿扎那韦 |
- |
198904-31-3 |
10mg,50mg,250mg,5g |
E181466 |
Entecavir
æ©æ›¿å¡éŸ¦ |
98% |
142217-69-4 |
250mg,1g |
D127186 |
Daclatasvir(BMS-790052) |
≥98% |
1009119-64-5 |
10mg,50mg,250mg |
M124903 |
MK-5172 |
98% |
1350514-68-9 |
5mg,10mg |
A126103 |
Asunaprevir
阿那匹韦 |
≥98% |
630420-16-5 |
5mg,10mg,50mg,250mg |
R126586 |
利托那韦
Ritonavir |
≥98% |
155213-67-5 |
10mg,50mg,250mg,500mg |
V127611 |
VX-222 (VCH-222, Lomibuvir) |
≥99% |
1026785-59-0 |
5mg,10mg,50mg |
D125841 |
达芦那韦
Darunavir |
98% |
206361-99-1 |
5mg,10mg,50mg,250mg,1g |
R129802 |
Raltegravir(MK-0518) |
≥97% |
518048-05-0 |
5mg,10mg,50mg,1g |
D127636 |
多替拉韦
Dolutegravir |
≥99% |
1051375-16-6 |
5mg,10mg,50mg |
L299096 |
洛比那韦
Lopinavir |
95% |
192725-17-0 |
10mg,50mg,250mg,1g |
L129320 |
洛比那韦
Lopinavir |
≥99% |
192725-17-0 |
10mg,50mg,100mg,250mg,1g |
æŠ‘åˆ¶æ–°åž‹å† çŠ¶ç—…æ¯’(2019-nCoV)的内切RNA酶的DTI预测结果
é¡¹ç›®å· |
ä¸æ–‡å称 |
è§„æ ¼ |
CAS |
包装 |
E135556 |
Efavirenz
ä¾æ³•éŸ¦ä»‘ |
≥98%(HPLC) |
154598-52-4 |
10mg,50mg,250mg,1g,5g |
A125825 |
Atazanavir
阿扎那韦 |
- |
198904-31-3 |
10mg,50mg,250mg,5g |
R126586 |
利托那韦
Ritonavir |
≥98% |
155213-67-5 |
10mg,50mg,250mg,500mg |
D127014 |
Danoprevir (ITMN-191) |
≥95% |
850876-88-9 |
2mg,5mg,25mg |
M124903 |
MK-5172 |
98% |
1350514-68-9 |
5mg,10mg |
D127636 |
多替拉韦
Dolutegravir |
≥99% |
1051375-16-6 |
5mg,10mg,50mg |
V127611 |
VX-222 (VCH-222, Lomibuvir) |
≥99% |
1026785-59-0 |
5mg,10mg,50mg |
L299096 |
洛比那韦
Lopinavir |
95% |
192725-17-0 |
10mg,50mg,250mg,1g |
L129320 |
洛比那韦
Lopinavir |
≥99% |
192725-17-0 |
10mg,50mg,100mg,250mg,1g |
D125841 |
达芦那韦
Darunavir |
98% |
206361-99-1 |
5mg,10mg,50mg,250mg,1g |
N137745 |
奈éžé‚£éŸ¦
Nelfinavir Mesylate |
98% |
159989-65-8 |
10mg,50mg,250mg |
T126775 |
Telaprevir
特拉匹韦 |
≥98% |
402957-28-2 |
5mg,10mg,50mg |
A126552 |
Abacavir
阿巴å¡éŸ¦ |
≥98.0% |
136470-78-5 |
1g,5g |
R129802 |
Raltegravir(MK-0518) |
≥97% |
518048-05-0 |
5mg,10mg,50mg,1g |
æŠ‘åˆ¶æ–°åž‹å† çŠ¶ç—…æ¯’(2019-nCoV)çš„2’-O-æ ¸ç³– 甲基转移酶的DTI预测结果
é¡¹ç›®å· |
ä¸æ–‡å称 |
è§„æ ¼ |
CAS |
包装 |
E135556 |
Efavirenz
ä¾æ³•éŸ¦ä»‘ |
≥98%(HPLC) |
154598-52-4 |
10mg,50mg,250mg,1g,5g |
A125825 |
Atazanavir
阿扎那韦 |
- |
198904-31-3 |
10mg,50mg,250mg,5g |
å‚考文献
Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model.
|
|